Section I
281 – 290 of 5061
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
The Vitamin D Receptor as a Prognostic Marker in Breast Cancer-A Cohort Study
- Contribution to journal › Article
-
Mark
Baseline breast tissue characteristics determine the effect of tamoxifen on mammographic density change
- Contribution to journal › Article
-
Mark
Progressive QTc prolongation and reduced heart rate variability in dementia with Lewy bodies compared to Alzheimer's disease
- Contribution to journal › Article
-
Mark
Has time to chemotherapy from primary debulking surgery in advanced ovarian cancer an impact on survival? - A population-based nationwide SweGCG study
- Contribution to journal › Article
-
Mark
Into the twilight zone – should ER-low breast cancer be treated as triple negative breast cancer?
- Contribution to journal › Debate/Note/Editorial
-
Mark
Hematological and renal toxicity in mice after three cycles of high activity [177Lu]Lu-PSMA-617 with or without human α1-microglobulin
- Contribution to journal › Article
-
Mark
Decoding pan-cancer complexity. Multiomic insights from the lung and breast
(2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancer
- Contribution to journal › Article
-
Mark
Population pharmacokinetic–pharmacodynamic model of subcutaneous bupivacaine in a novel extended-release microparticle formulation
- Contribution to journal › Article
-
Mark
Retrospective genetic testing (Traceback) in women with early-onset breast cancer after revised national guidelines : a clinical implementation study
- Contribution to journal › Article
